Toru Ikezoe Selected Research

Toru Ikezoe Research Topics

6	Abdominal Aortic Aneurysm 01/2023 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 11/2021
2	Aneurysm (Aneurysms) 01/2022 - 01/2021
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Pathologic Constriction (Stenosis) 12/2022
1	Atherosclerosis 10/2022
1	Vascular Diseases (Vascular Disease) 10/2022
1	Stroke (Strokes) 10/2022
1	COVID-19 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 11/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Hypercholesterolemia 01/2021

2	ApolipoproteinsIBA 01/2023 - 01/2021
2	Angiotensin IIIBA 01/2023 - 11/2021
2	LipidsIBA 01/2023 - 01/2021
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2021
2	Pancreatic Elastase (Elastase)IBA 01/2021 - 01/2021
1	Disulfiram (Antabuse)FDA Link 01/2023
1	CollagenIBA 01/2023
1	Advanced Glycation End ProductsIBA 01/2023
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Prolyl-Hydroxylase InhibitorsIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022
1	LigandsIBA 11/2021
1	Angiotensin-Converting Enzyme 2IBA 11/2021
1	AngiotensinsIBA 11/2021
1	angiotensin I (1-7)IBA 11/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	CytokinesIBA 01/2021
1	ElastinIBA 01/2021
1	Proprotein Convertase 9IBA 01/2021

1	Subcutaneous Infusions 01/2023
1	Therapeutics 12/2022
1	Intraperitoneal Injections 01/2021